Bnp Paribas Asset Management Holding S.A. Ascendis Pharma A/S Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 276,984 shares of ASND stock, worth $53 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
276,984
Previous 330,153
16.1%
Holding current value
$53 Million
Previous $51.5 Million
7.09%
% of portfolio
0.12%
Previous 0.14%
Shares
7 transactions
Others Institutions Holding ASND
# of Institutions
279Shares Held
61.8MCall Options Held
151KPut Options Held
226K-
Ra Capital Management, L.P. Boston, MA10.3MShares$1.97 Billion33.28% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$1.05 Billion4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.22MShares$999 Million13.16% of portfolio
-
Janus Henderson Group PLC London, X04.49MShares$859 Million0.4% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.26MShares$815 Million1.14% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $10.7B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...